Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 14048-14049 [2014-05378]
Download as PDF
<![CDATA[
14048
Federal Register / Vol. 79, No. 48 / Wednesday, March 12, 2014 / Notices
expiration date 8/31/2010)—National
Institute for Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
NIOSH has the responsibility under
Public Law 91–596 section 20
(Occupational Safety and Health Act of
1970) to conduct research relating to
innovative methods, techniques, and
approaches for dealing with
occupational safety and health
problems.
Commercial fishing is one of the most
dangerous occupations in the United
States, with a fatality rate 30 times
higher than the national average. Most
fishermen who die on the job drown
subsequent to a vessel sinking (52%) or
fall overboard (31%). Because drowning
is the leading cause of death for
commercial fishermen, its prevention is
one of the highest priorities for those
who work to make the industry safer.
The risk of drowning for commercial
fisherman is high, yet most fishermen
do not wear Personal Flotation Devices
(PFDs) while on deck. Of the 182
fishermen who died from falls
overboard between 2000 and 2011 none
operating in Alaska fisheries. This
questionnaire will contain questions
that measure fishermen’s risk
perceptions, safety attitudes, and beliefs
about PFDs, as well as recognition and
influence of NIOSH risk communication
activities. The questionnaire will take
approximately 20 minutes to complete.
Consistent with the previous OMBapproved data collection protocol, the
sample size was determined to be 400
total respondents to achieve a 95%
confidence level. Two hundred
independent respondents will be
sampled just prior to the 2014 season
and an additional two hundred will be
sampled just prior to the 2015 season.
This study has the potential to greatly
benefit the fishing industry. As a result
of previous research, NIOSH has gained
a baseline understanding of fishermen’s
reasons for not wearing PFDs. With this
empirical data at hand, an intensive risk
communication intervention has been
developed to address fishermen’s
concerns and remove the barriers that
are currently in place.
There are no costs to respondents
other than their time. The total
estimated annual burden hours are 134.
of them were wearing a personal
flotation device (PFD). Many were
within minutes of being rescued when
they lost their strength and disappeared
under the surface of the water.
NIOSH recently conducted a study to
establish a baseline understanding of
Alaska fishermen’s perceptions of risk,
safety attitudes, and beliefs about PFDs;
and to evaluate a variety of modern
PFDs with commercial fishermen to
discover the features and qualities that
they like and dislike. Based upon these
results, NIOSH developed an intensive
risk communication strategy to raise
awareness to newer (potentially more
satisfactory) PFD models, to address
barriers, and to encourage increased
PFD use among fishermen working in
Alaska.
The purpose of this study is to first,
determine if fishermen’s perception of
risk, safety attitudes, and beliefs about
PFDs has shifted or remained the same
since the implementation of the initial
survey (2008–2009); and second, to
evaluate the effectiveness of the NIOSH
intensive risk communication
intervention.
NIOSH is requesting OMB approval to
administer a survey to fishermen
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Fishermen .........................................
2014 Fishing Season: Fishing for
Facts: A survey of fishermen’s
opinions about the risk of falls
overboard and PFDs.
2015 Fishing Season: Fishing for
Facts: A survey of fishermen’s
opinions about the risk of falls
overboard and PFDs.
Fishermen .........................................
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–05273 Filed 3–11–14; 8:45 am]
BILLING CODE 4163–18–P
tkelley on DSK3SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Cooperative Research
VerDate Mar<15>2010
17:51 Mar 11, 2014
Jkt 232001
Frm 00072
Fmt 4703
Sfmt 4703
Average
burden per
response
(in hrs)
Total
burden
(in hrs)
200
1
20/60
67
200
1
20/60
67
Agreements to the World Trade Center
Health Program (U01) PAR 12–126,
initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Times and Dates:
8:00 a.m.–5:00 p.m., April 1, 2014
(Closed);
8:00 a.m.–12:00 p.m., April 2, 2014
(Closed).
Place: Atlanta Marriott Century
Center, 2000 Century Boulevard NE.,
Atlanta, Georgia 30345, Telephone (404)
325–0000.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
PO 00000
Number of
responses per
respondent
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Cooperative Research Agreements
Related to the World Trade Center
Health Program (U01) PAR 12–126.’’
Contact Person for More Information:
Nina Turner, Ph.D., Scientific Review
Officer, CDC/NIOSH, 1095 Willowdale
Road, Mailstop G905, Morgantown,
West Virginia 26505, Telephone: (304)
285–5975.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
E:\FR\FM\12MRN1.SGM
12MRN1
Federal Register / Vol. 79, No. 48 / Wednesday, March 12, 2014 / Notices
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
Gary Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–05377 Filed 3–11–14; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2014–05378 Filed 3–11–14; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Centers for Medicare & Medicaid
Services
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[CMS–3286–FN]
Centers for Disease Control and
Prevention
tkelley on DSK3SPTVN1PROD with NOTICES
Request for Nominations of
Candidates To Serve on the World
Trade Center Health Program
Scientific/Technical Advisory
Committee (the STAC or the
Committee), Centers for Disease
Control and Prevention, Department of
Health and Human Services
Correction: This notice was originally
published in the Federal Register on
January 30, 2014 Volume 79, Number
20, page 4911. This notice is to
announce the extension of submission
for potential nominees.
Nominations must be submitted
(postmarked or electronically received)
by March 31, 2014. Please submit
written nominations (one original and
two copies) to the following address
only: NIOSH Docket 229–B, c/o Zaida
Burgos, Committee Management
Specialist, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1600 Clifton Rd. NE., MS: E–20, Atlanta,
Georgia 30333 or electronic nominations
to: nioshdocket@cdc.gov. Attachments
in Microsoft Word are preferred.
Telephone and facsimile submissions
cannot be accepted.
For further information, please
contact: Paul Middendorf, Senior Health
Scientist, 1600 Clifton Rd. NE., MS: E–
20, Atlanta, GA 30333; Telephone (404)
498–2500 (this is not a toll-free
number); email pmiddendorf@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
VerDate Mar<15>2010
17:51 Mar 11, 2014
Jkt 232001
Medicare and Medicaid Programs;
Application From the Joint
Commission for Continued Approval of
Its Home Health Agency (HHA)
Accreditation Program
Centers for Medicare and
Medicaid Services, HHS.
ACTION: Final Notice.
AGENCY:
This notice announces our
decision to approve the Joint
Commission for continued recognition
as a national accreditation program for
Home Health Agencies (HHAs) seeking
to participate in the Medicare or
Medicaid programs. An HHA that
participates in Medicaid must, in
accordance with § 440.70(d) meet the
Medicare participation requirements,
and may demonstrate compliance
through deemed status, as provided for
under § 488.6(b), with the exception of
the capitalization requirements at
§ 489.28.
DATES: Effective Date: This final notice
is effective March 31, 2014 through
March 31, 2020.
FOR FURTHER INFORMATION CONTACT:
Lillian Williams, (410) 786–8636,
Patricia Chmielewski, (410) 786–6899,
or Monda Shaver, (410) 786–3410.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
Under the Medicare program, eligible
beneficiaries may receive covered
services from a HHA provided certain
requirements are met. Sections 1861(o)
and 1891 of the Social Security Act (the
Act), establish distinct criteria for
facilities seeking to participate in
Medicare as an HHA. Regulations
concerning Medicare provider
agreements are at part 489 and those
pertaining to activities relating to the
survey and certification of facilities are
at part 488. The regulations at part 484
specify the minimum conditions that a
HHA must meet to be certified to
participate in the Medicare program.
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
14049
Generally, to enter into a Medicare
agreement, a HHA must first be certified
by a state survey agency as complying
with the conditions set forth in part 484
of the Medicare regulations. Thereafter,
the HHA is subject to regular surveys by
a State survey agency to determine
whether it continues to meet these
requirements. There is an alternative,
however, to surveys by State agencies.
Section 1865(a) of the Act provides
that, if an accrediting organization is
recognized by the Secretary as having
standards for accreditation that meet or
exceed all applicable Medicare
conditions or requirements, as well as
comparable survey procedures, a
provider entity accredited under the
national accrediting body’s approved
Medicare accreditation program would
be deemed to meet the Medicare
conditions or requirements.
Accreditation under an approved
Medicare accreditation program of an
accrediting organization is voluntary
and is not required for Medicare
participation.
A national accrediting organization
applying for approval of its
accreditation program in accordance
with section 1865(a)(2) and (3) of the
Act and our implementing regulations at
part 488, subpart A, must provide us
with reasonable assurance that the
accrediting organization requires the
accredited provider entities to meet
requirements that are at least as
stringent as all of the applicable
Medicare conditions or requirements.
Our regulations concerning the approval
of accrediting organizations are set forth
at § 488.4 and § 488.8(d)(3). The
regulations at § 488.8(d)(3) require
accrediting organizations to reapply for
continued approval of a Medicare
accreditation program every 6 years or
sooner, as determined by us.
The Joint Commission’s current term
of approval for its HHA accreditation
program expires March 31, 2014.
II. Approval of Deeming Organizations
Section 1865(a)(2) of the Act and our
regulations at § 488.8(a) require that our
findings concerning review and
approval of a national accrediting
organization’s requirements consider,
among other factors, the applying
accrediting organization’s requirements
for accreditation; its survey procedures;
its ability to provide adequate resources
for conducting required surveys and to
furnish us information for use in
enforcement activities; its monitoring
procedures for provider entities found
not in compliance with the conditions
or requirements; and its ability to
provide us with the necessary data for
validation.
E:\FR\FM\12MRN1.SGM
12MRN1
]]>Agencies
[Federal Register Volume 79, Number 48 (Wednesday, March 12, 2014)]
[Notices]
[Pages 14048-14049]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05378]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Cooperative Research
Agreements to the World Trade Center Health Program (U01) PAR 12-126,
initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Times and Dates:
8:00 a.m.-5:00 p.m., April 1, 2014 (Closed);
8:00 a.m.-12:00 p.m., April 2, 2014 (Closed).
Place: Atlanta Marriott Century Center, 2000 Century Boulevard NE.,
Atlanta, Georgia 30345, Telephone (404) 325-0000.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Cooperative Research Agreements Related to the World Trade Center
Health Program (U01) PAR 12-126.''
Contact Person for More Information: Nina Turner, Ph.D., Scientific
Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop G905,
Morgantown, West Virginia 26505, Telephone: (304) 285-5975.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of
[[Page 14049]]
meetings and other committee management activities, for both the
Centers for Disease Control and Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary Johnson,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2014-05378 Filed 3-11-14; 8:45 am]
BILLING CODE 4163-18-P
